EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC 4.0

Clinical Validation of Venetoclax Volumetric Microsampling in Patients with Leukemia with Assessment of Whole-Blood-to-Plasma Conversion Strategies and Self-Microsampling Feasibility

A D Levens iD, J Rijstenbil, E Metscher, P von dem Borne, A Albersen, J J Swen, D J A R Moes iD

Clinical Pharmacokinetics · 2026-06 · 65 (6) · 863-882

DOI: 10.1007/s40262-026-01635-3 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Clinical Pharmacokinetics, online erschienen am 22.04.2026. Verfasst von A D Levens und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Sulfonamides, Leukemia, Lymphocytic, Chronic, B-Cell, Antineoplastic Agents, Bridged Bicyclo Compounds, Heterocyclic. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulfonamidesLeukemia, Lymphocytic, Chronic, B-CellAntineoplastic AgentsBridged Bicyclo Compounds, HeterocyclicLeukemia, Myeloid, AcuteBlood Specimen CollectionHumansFemaleAgedMiddle AgedMaleFeasibility StudiesDrug MonitoringAdultAged, 80 and overDried Blood Spot Testing

Substanzen

SulfonamidesvenetoclaxAntineoplastic AgentsBridged Bicyclo Compounds, Heterocyclic

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands. d.j.a.r.moes@lumc.nl.

ORCID-Profile: A D Levens, D J A R Moes

Zitieren

APA

Levens, A. D., Rijstenbil, J., Metscher, E., von dem Borne, P., Albersen, A., Swen, J. J., & Moes, D. J. A. R. (2026). Clinical Validation of Venetoclax Volumetric Microsampling in Patients with Leukemia with Assessment of Whole-Blood-to-Plasma Conversion Strategies and Self-Microsampling Feasibility. Clinical Pharmacokinetics, 65(6), 863-882. https://doi.org/10.1007/s40262-026-01635-3

Vancouver

Levens AD, Rijstenbil J, Metscher E, von dem Borne P, Albersen A, Swen JJ, et al. Clinical Validation of Venetoclax Volumetric Microsampling in Patients with Leukemia with Assessment of Whole-Blood-to-Plasma Conversion Strategies and Self-Microsampling Feasibility. Clinical Pharmacokinetics. 2026;65(6):863-882. doi:10.1007/s40262-026-01635-3

BibTeX
@article{Levens2026,
  author = {Levens, A D and Rijstenbil, J and Metscher, E and von dem Borne, P and Albersen, A and Swen, J J and Moes, D J A R},
  title = {Clinical Validation of Venetoclax Volumetric Microsampling in Patients with Leukemia with Assessment of Whole-Blood-to-Plasma Conversion Strategies and Self-Microsampling Feasibility},
  journal = {Clinical Pharmacokinetics},
  year = {2026},
  volume = {65},
  number = {6},
  pages = {863--882},
  doi = {10.1007/s40262-026-01635-3}
}
Kostenlos starten →